Institution statistics

HUMANITAS MIRASOLE SPA - Italy 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:> 1000
Total Number of Projects:800-900
2018
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:900-1000
Total Number of Projects:> 1000
Networking Rank (Reputation):300-400
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:700-800
Total Project Funding per Partner:200-300
Total Number of Projects:700-800
Networking Rank (Reputation):> 1000
Partner Constancy:600-700
Project Leadership Index:700-800
2012
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:400-500
Total Number of Projects:69
Total Project Funding:> 1000
Networking Rank (Reputation):900-1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:300-400
Total Number of Projects:900-1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 33
As coordinator: 3
As participant: 18
Sole participant: 12
Coordinator / Participant Ratio: 0.17*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 183.473 0 183.473 1
2019 339.750 6.844.802 1.312.750 2 2
2018 5.596.928 2.000.000 1.651.995 1 1
2017 168.277 0 168.277 1
2016 0 3.895.551 516.123 1
2015 1.668.277 8.477.516 4.615.358 2 2
2014 187.415 0 187.415 1
2013 0 2.350.342 343.720 1
2012 2.600.000 0 2.600.000 2
2011 200.000 10.959.000 169.333 2 1
2010 100.000 0 100.000 1
2009 0 5.916.675 2.521.937 3
2008 100.000 10.235.585 587.409 1 1
2006 0 2.467.314 274.146 1
2005 11.889.096 30.581.086 1.718.905 1 3
2004 0 7.400.000 321.739 1
2003 0 15.550.000 518.333 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR6
KING'S COLLEGE LONDON5
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE4
INSTITUTE FOR RESEARCH IN BIOMEDICINE4
KATHOLIEKE UNIVERSITEIT LEUVEN4
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE3
CHARITE UNIVERSITAETSMEDIZIN BERLIN3
DEUTSCHES RHEUMAFORSCHUNGSZENTRUM BERLIN3
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI3
ISTITUTO SUPERIORE DI SANITA3
MILTENYI BIOTEC3
TECHNISCHE UNIVERSITAET MUENCHEN3
UNIVERSITY COLLEGE LONDON3
ACADEMISCH ZIEKENHUIS GRONINGEN2
ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE2
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS2
DOMPE PHA R MA2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
GENOPOLIS FUNCTIONAL GENOMICS CONSORTIUM2
INSERM TRANSFERT2
KAROLINSKA INSTITUTE2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN2
MAXDELBRUECKCENTRUM FUER MOLEKULARE MEDIZIN2
MEDICAL RESEARCH COUNCIL2
MOTOR NEURONE DISEASE ASSOCIATION2
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD2
THE UNIVERSITY OF SHEFFIELD2
UNIVERSITA DEGLI STUDI DI FIRENZE2
UNIVERSITA DEGLI STUDI DI MILANO BICOCCA2
UNIVERSITAIR MEDISCH CENTRUM UTRECHT2
UNIVERSITE LIBRE DE BRUXELLES2
UNIVERSITE PIERRE ET MARIE CURIE PARIS VI2
UNIVERSITY OF LAUSANNE2
WEIZMANN INSTITUTE OF SCIENCE2
A PERSIDIS & SIA OE1
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ACCELERO BIOANALYTICS1
ADVANCED PRACTICAL DIAGNOSTICS1
AFFECTIS PHAMACEUTICALS1
AMC MEDICAL RESEARCH BV1
AREXIS AB1
ARGOS THERAPEUTICS INC1
ASSOCIATION GENETHON1
AT4 WIRELESS1
AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A C R A F S P A1
BERNHARD NOCHT INSTITUT FUER TROPENMEDIZIN1
BI TECHNOLOGY A/S BANK INVEST GROUP1
BIOKINE THERAPEUTICS1
BIOMEDCODE HELLAS1
BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING1
BIOMERIEUX1
BIOMEVA1
BIOVEX1
BIOVITRUM AB1
BIOXELL1
BRUCELLS1
BRUSCHETTINI1
CANCER RESEARCH UK1
CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE TOURS1
CENTRE HOSPITALIER UNIVERSITAIRE1
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS1
CENTRE NATIONAL DE RECHERCHE SCIENTIFIQUE1
CENTRE NATIONALE DE LA RECHERCHE SCIENTIFIQUE1
CENTREHOSPITALIERUNIVERSITAIRE IGNACE DEEN CONAKRY1
CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
CHIRON1
CHRISTIAN DE DUVE INSTITUTE OF CELLULAR PATHOLOGY1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
CONCORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
CONSIGLIO NAZIONALE DELLE RICERCHE1
CONSIGLIO NAZIONALE DELLE RICERCHE ISTITUTO DI BIOLOGIA CELLULARE1
CROSSLINKS BV1
CSEM CENTRE SUISSE D'ELECTRONIQUE ET DE MICROTECHNIQUE SA RECHERCHE ET DEVELOPPEMENT1
CYTOS BIOTECHNOLOGY1
DESCIN BV1
DEUTSCHES KREBSFORSCHUNGSZENTRUM1
EHT TECHNOLOGIES1
ENABLINGMNT1
ERASMUS MC DANIEL DEN HOED CANCER CENTER1
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON1
EUROPEAN MOLECULAR BIOLOGY LABORATORY1
FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA1
FONDAZIONE MULTIMEDICA ONLUS1
FOUNDATION BIOLOGICAL PSYCHIATRY1
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V1
FRIEDRICH ALEXANDER UNIVERSITAET ERLANGEN NUERNBERG1
FRIEDRICHSCHILLERUNIVERSITAET JENA1
GENERAL TEACHING HOSPITAL IN PRAGUE1
GENOME RESEARCH1
GoeTEBORG UNIVERSITY1
GOETEBORGS UNIVERSITET1
HARTERAAD1
HEALTH PROTECTION AGENCY1
HELENA VENIZELOU MATERNITY HOSPITAL1
HELMHOLTZ ZENTRUM FUER INFEKTIONSFORSCHUNG1
ICON CLINICAL RESEARCH LIMITED1
IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE1
IMMUNE DISEASE INSTITUTE INC1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
Constancy:

Total number of partners:264

Partner loyalty:
Frequent Partner: (> 2 projects): 47
Rare Partner: 217

Frequent / Rare Partner Ratio: 0.22

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES14
RTD HORIZONTAL TOPICS8
SOCIAL AND ECONOMIC CONCERNS4
PHYSICAL AND EXACT SCIENCES1
AGRICULTURE AND MARINE RESOURC1

Project overview:

Start dateProjectacronymrolefundingpartners
2020-03-16Identification and functional validation of novel enhancer sequences involved in pituitary gland development and pathology Pituitary enhancerscoordinator183.4731
2019-07-16Role of the Maternal Gut Microbiota in Immune Activation at the Maternal-Foetal Interface: Impact on Preeclampsia and Offspring's Immune Development DaPhNIscoordinator168.2771
2019-06-01Physiological consequences of Protocadherin-10 sumoylation on neuronal function. SUMO-PCDH10coordinator171.4731
2019-06-01TRAIN-HEART TRAIN-HEARTparticipant3.940.38916
2019-05-01Light and Organic Nanotechnology for Cardiovascular Disease LION-HEARTEDparticipant2.904.4148
2018-07-01Direct cell reprogramming therapy in myocardial regeneration through an engineered multifunctional platform integrating biochemical instructive cues BIORECARparticipant2.000.0002
2018-01-01Safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS) TUDCA-ALScoordinator5.596.92810
2017-01-01In vivo engineering of monocytes loaded with nano-chemotherapeutic formulations: a novel live-cell mediated drug delivery system for the treatment of cancer MONONANOCHEMcoordinator168.2771
2016-03-01European Sepsis Academy: towards new biomarkers to improve sepsis management ESA -ITNparticipant3.895.5518
2015-09-01Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients MIROCALSparticipant5.980.43512
2015-09-01PTX3 in Humoral Innate Immunity PHIIparticipant2.497.0811
2015-09-01Generation and maintenance of long-lived memory T cells in humans PERSYSTcoordinator1.500.0001
2015-05-20Development and Evaluation of Nanomedicines for Cancer Treatment through Immunomodulation: Targeting Tumor-Associated Macrophages NANOTAMcoordinator168.2771
2014-04-01mRNA translational regulation in heart failure MRNA IN HEARTcoordinator187.4151
2013-04-01Signalling compartmentalization and vesicle Trafficking at the Phagocytic Synapses STEPSparticipant2.350.3422
2012-10-01Epigenetics and microRNAs in Myocardial Function and Disease CARDIOEPIGENcoordinator2.500.0001
2012-08-01Improving adoptive T cell transfer immunotherapy for cancer with T memory stem cells STEMIMMUNEcoordinator100.0001
2011-10-01ICT-enabled, cellular artificial liver system incorporating personalized patient management and support d-LIVERparticipant10.959.00015
2011-08-01Role of microRNAs 143 and 145 in cardiovascular physiology and disease: from bench to bedside From Bench to Bedsidcoordinator100.0002
2011-02-01Characterization of NK cell distributions and functions in human tissues in HIV-1 pathogenesis CNKHIVcoordinator100.0001
2010-08-01Global microRNA profiling of normal and Pbx1-null hematopoietic stem cells and progenitors for the identification of new regulators of the balance between self-renewal and differentiation HSC self-renewalcoordinator100.0001
2009-10-01Advanced Teaching and TRaining for Adoptive Cell Therapy ATTRACTparticipant2.838.53914
2009-06-01The humoral innate immune system: long pentraxins as a paradigm HIISparticipant2.066.2001
2009-03-16A coordinated and structured international post-doctoral program to foster trans-national mobility and independent career of scientists in biomedicine SIPODparticipant1.011.9364
2008-11-01Early diagnosis, treatment and prevention of mood disorders targetting the activated inflammatory response system MOODINFLAMEparticipant10.235.58521
2008-03-01Role of innate immunity in the pathogenesis of autoimmune diseases RIISPADcoordinator100.0001
2006-12-01Development of a new DNA array-based diagnostic system (IBDchip) to predict clinical course, development of complications, and response to therapy in patients with inflammatory bowel disease (IBD) IBDCHIPparticipant2.467.3149
2005-11-01Adoptive engineered T-cell Targeting to Activate Cancer Killing ATTACKparticipant11.981.08617
2005-11-01Innovative chemokine-based therapeutic strategies for autoimmunity and chronic inflammation INNOCHEMcoordinator11.889.09629
2005-01-01Integrated functional genomics in mutant mouse models as tools to investigate the complexity of human immunological disease MUGENparticipant11.000.00030
2005-01-01Dendritic cells for novel immmunotherapies DC-THERAparticipant7.600.00032
2004-10-01The control of embryo implantation: studies of gene expression, protein profiles / functions at the utero embryonic level: cellular and molecular developmental events at the feto maternal interface EMBICparticipant7.400.00023
2003-12-01Mucosal Vaccines for Poverty Related Diseases MUVAPREDparticipant15.550.00030

Alias institution names:
  • HUMANITAS MIRASOLE

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum